Krambeck Amy, Wijnstok Nienke, Olbert Peter, Mitroi George, Bariol Simon, Shah Hemendra N, El-Abd Ahmed S, Onal Bulent, de la Rosette Jean
1 Department of Urology, IU Health , Indianapolis, Indiana.
2 Department of Urology, AMC University Hospital , Amsterdam, The Netherlands .
J Endourol. 2017 Jan;31(1):20-26. doi: 10.1089/end.2016.0514. Epub 2016 Nov 29.
Although ureteroscopy (URS) has been established as a viable treatment for stones in obese patients, its safety and success has not been fully elucidated. The current study describes the worldwide prevalence of obesity in patients with urolithiasis and examines trends in URS outcomes, safety, and efficacy.
This study utilized the Clinical Research Office of the Endourological Society (CROES) URS Global Study, which was a prospective, multicenter study including 11,885 patients treated with URS for urinary stones at 1 of 114 urology departments across 32 countries. The relationship between body mass index (BMI), diabetes, and creatinine, with retreatment, stone-free rates, complications, and long hospital stay, was examined with a multivariate logistic regression analyses.
Of the 10,099 URS patients with BMI data, 17.4% were obese and 2.2% were super obese. Overall, 86.7% patients were stone free and 16.8% required retreatment. Higher BMI was associated with lower stone-free rates, and any deviation from normal weight was associated with higher retreatment rates. In multivariate analysis controlling for several variables including stone size, the association between BMI and lower stone-free rates with higher retreatment rates persisted. Intraoperative complications occurred in 518 (5.1%) patients, and 343 (3.4%) experienced a postoperative complication. Postoperative complications were more frequent in the underweight and super obese subjects, and there was no relationship between BMI and intraoperative complications.
Although URS for stone disease was found to be an overall safe procedure for obese and super obese patients, efficacy of the procedure may be lower compared with normal-weight subjects and higher retreatment rates may be necessary.
尽管输尿管镜检查(URS)已被确立为肥胖患者结石的一种可行治疗方法,但其安全性和成功率尚未完全阐明。本研究描述了全球尿石症患者的肥胖患病率,并探讨了URS结果、安全性和疗效的趋势。
本研究利用了腔内泌尿外科协会临床研究办公室(CROES)的URS全球研究,这是一项前瞻性、多中心研究,纳入了32个国家114个泌尿外科科室中接受URS治疗尿路结石的11,885例患者。通过多因素逻辑回归分析,研究了体重指数(BMI)、糖尿病和肌酐与再次治疗、结石清除率、并发症及住院时间延长之间的关系。
在10,099例有BMI数据的URS患者中,17.4%为肥胖患者,2.2%为超级肥胖患者。总体而言,86.7%的患者结石清除,16.8%需要再次治疗。较高的BMI与较低的结石清除率相关,任何体重偏离正常均与较高的再次治疗率相关。在控制包括结石大小等多个变量的多因素分析中,BMI与较低结石清除率及较高再次治疗率之间的关联依然存在。518例(5.1%)患者发生术中并发症,343例(3.4%)经历术后并发症。术后并发症在体重过轻和超级肥胖患者中更常见,BMI与术中并发症之间无关联。
尽管对于肥胖和超级肥胖患者,URS治疗结石病总体上是安全的,但与正常体重患者相比,该手术疗效可能较低,可能需要更高的再次治疗率。